А Б В Г Д Е Ж З И К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Э Ю Я
0-9 A B C D I F G H IJ K L M N O P Q R S TU V WX Y Z #


Чтение книги "Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников" (страница 69)

   Глава 6

   1. Gerhard Schrauzer, Ph.D., of the University of California cited in Better Nutrition, Nov, 1989, v 51, no. 11, p. 14 (2).
   2. Redhook., April, 1989, v 172, n6, p. 96 (5).
   3. Spallholz, J.E., Stewart, J.R., 1989. Advances in the role of minerals in immunobiology. Center for Food and Nutrition, Texas Tech University, Lubbock 79409. Biol Trace Elem Res Mar, 19 (3) pp. 129–151.
   4. Archives of Environmental Health, September/October 1976.
   5. Knekt, Paul, and others, 1988. Selenium Deficiency and Increased Risk of Lung Cancer. Abstract of paper read at the Fourth International Symposium on Selenium in Biology and Medicine, Tubingen, West Germany, July.
   6. Reinhold, U., and others, 1988. Selenium Deficiency and Lethal Skin cancer. Abstract of paper read at the Fourth International Symposium on Selenium in Biology and Medicine, Tubingen, West Germany, July.
   7. Lockwood, K., Moesgaard, S., Hanioka, Т., and Folkers, K., 1994. Apparent partial remission of breast cancer in chigh risk’ patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Qi0. Mol Aspects Med, 15, Suppls, 231–240. See also: Lockwood, K., Moesgaard, S. and Folkers, K., 1994. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and Biophysical Research Communications, 199, 3, 30 March, 1504–1508. See also: Lockwood, K., Moesgaard, S„Yamamoto, T. and Folkers, K., 1995. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and Biophysical Research Communications, 212, 1, 172–177.
   8. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, 1982. Geneva: World Health Organization, International Agency for Research on Cancer, 1972 – present. (Multivolume work). V29, p. 282. See also Osihi, Shinshi, 1990. Effects of phthalic acid esters on testicular mitochondrial functions in the rat Archives of Toxicology, March, V64 n2, p. 143 (5).
   9. Holland, J C., 1996. Cancer’s Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158–161.
   10. Heason, P., Deep Relaxation available from 37 Tollerton Lane, Tollerton, Nottingham.
   11. Based on Holland, J C., 1996. Cancer’s Psychological Challenges. Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 158–161.
   12. Trichopoulos, Dimitrios, Li, Frederick, P. and Hunter, David J., 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.
   13. Levy, Len, 1998, Biomed II: Exposure to low-level benzene, p. 76. In: Institute for Environment and Health, Annual Report. 100 pp.
   14. Pearson, J.K., 2000. The Air Quality Challenge, American Society of Automotive Engineers and HMSO.
   15. North Atlantic Treaty Organisation, 1988. International Toxicity Equivalency Factor (I-TEF) method of risk assessment for complex mixtures of dioxins and related compounds. Pilot study on international information exchange on dioxins and related compounds. CCMS Report Number 176, Environmental Protection Agency, Washington DC, USA. Department of Health, 1995. Statement by the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment on the US EPA draft, health assessment document for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Dept of Health, London.
   16. EPA Dioxin Reassessment Summary, 1994 4/94 – Vol. 1, CERI/ORD Publication Centre, USEPA.
   17. MAFF, 1997. Dioxins and PCBs in retail cows’ milk in England. Food Surveillance No. 136, December, Ministry of Agriculture, Fisheries and Food, London.
   18. Tanabe, S., 1988. PCB Problems in the Future: Foresight from Current Knowledge. Environmental Pollution, 50, 5-28.
   19. Department of the Environment, 1989. Dioxins in the Environment Pollution Paper, No. 27, HMSO, London.
   20. MAFF, 1997. Dioxins and Polychlorinated Biphenyls in Fish Oil Dietary Supplements and Licensed Medicines. Food Surveillance Information Sheet, № 106, Ministry of Agriculture, Fisheries and Food, London.
   21. MAFF, 1996. Dioxins In Human Milk. Food Surveillance Information Sheet, № 88, Ministry of Agriculture, Fisheries and Food, London.
   22. MAFF, 1996. Polychlorinated Biphenyls in Food – UK Dietary Intakes. Food Surveillance Information Sheet, № 89, Ministry of Agriculture, Fisheries and Food, London.
   23. Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.
   24. Shin, R.J. and others, 1999. Development of a bioassay system for identification of Endocrine Disrupters. Proc 2nd Intern. Symp. On Advanced Env. Monitoring, Kwangju, Korea.
   25. Soto, A.M. and others, 1992. An in culture bioassay to assess the estrogenicity of xenobiotics. In: Chemically-induced alterations in sexual and functional development. The wildlife/ human connection. Vol. 21, Colborn T.C, Clement ed., Princeton Scientific Publishing, 295–309. See also: Soto, A.M. and others, 1995. The E-SCREEN assay as a tool to Identify estrogens: An update on estrogenic environmental pollutants. In: Estrogens in the Environment, Environmental Health Perspectives,113–122.
   26. Davis, Devra Lee, Axelrod, Deborah, Osborne, Michael P. and Telang, Nitin Т., 1997. Environmental influences on Breast Cancer Risk, World Resources Institute, Washington, DC, USA, Science and Medicine. May/June.
   27. Colborn, Т., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures, Dutton, Penguin Books, USA.
   28. Dyson, Т., 1999. Prospects for feeding the world. British Medical Journal, 319, 988–991.
   29. Reuters, 8 October 1998.
   30. McMurry, Laura М., Oethinger, Margaret, Levy, Stuart B., 1998. Triclosan targets lipid synthesis. Nature, 394, 6693, 531–532.
   31. Trichopoulos, Dimitrios, Li, Frederick, V. and Hunter, David J, 1996. What Causes Cancer? Scientific American, Special Issue, What you need to know about Cancer, September, 275, 3, 80–85.

   Глава 7

   1. Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. Am. J Clin. Nutr, 59, Suppl., 11 535-11 615.
   2. Packham, D.E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes. October.
   3. Packham, D.E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October.
   4. Association of University Teachers. Efficiency Gains or Quality Losses? 1996 (Based on DfEE and Welsh Office figures).
   5. Bok, D., 1990. In: Universities and the Future of America, Duke University Press, Durham NC.
   6. Glantz, S.A., 1996. Times Higher Education Supplement, 6 September, p. 15. and Glantz, S.A.,Slade, J., Bero, L.A., Hanauer, P. and Barnes, D.E., 1996. The Cigarette Papers, University of California Press.
   7. Packham, D.E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham, David and Tasker, Mary, 1997. Industry and the academy – a Faustian contract. Industry and Higher Education, April, 85–90.
   8. Packham, D.E., 1999. Impacts of Commercialisation and Privatisation on Capabilities for Scientific Advice, Oracles or Scapegoats? IPMS Conference notes, October. See also: Packham,
   David and Tasker, Mary, 1997. Industry and the academy– a Faustian contract. Industry and Higher Education, April, 85–90.
   9. Jasanoff, S., 1997. Civilization and madness: the great BSE scare of 1996. Public Understand. Sei. 6, 221–232.
   10. McMichael, A.J. and Powles, J.W, 1999. Human numbers, environment, sustainability and health. British Medical Journal, 319, 9 October, 977–980.

   Дополнение к главе 1

   1. www.nlm.nih.gov/medlineplus/ency/article/002919.htm
   2. McKenna, Claire, 2002. UK has highest reduction in deaths from lung and breast cancer. BMJ, 325, 63.
   3. Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678–679.
   4. Anon, 2006. Screening for breast cancer. BMJ, 332, 499–500.
   5. www.nlm.nih.gov/medineplus/ency/article/002919.htm
   6. e.g. Baum, М., 2000. Survival and reduction in mortality from breast cancer – Impact of mammographic screening is hot clear (Letter). BMJ, 321, 1470.
   7. Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
   8. Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
   9. Josefson, Deborah, 2002. Breast self-examination does not improve cancer survival. BMJ, 325, 793.
   10. Zackrisson S. and others, 2006. Rare of over-diagnosis of breast cancer 15years after end of Malmo mammographic screening trial; follow up study. BMJ, 332, 689–692.
   11. Anon, 2006. Screening for breast cancer. BMJ, 332, 499–500.
   12. Symonds, R. Paul, 2002. Cancer biology may be more important than diagnostic delay. BMJ, 325, 774.
   13. Spurgeon, David, 2002. Annual mammography in women in their 40s does not cut death rate. BMJ, 325, 563.
   14. www.cancerscreening.nhs.uk/breastscreen
   15. White, Caroline, 2002. ‘Unacceptable’ errors found in breast screening process. BMJ, 324, 933.
   16. UK National Radiological Protection Board, www.nrpb.org/ radiation_topics/risks/exposure.htm
   17. Irwig, Les, 2006. Evaluating new screening tests for breast cancer. BMJ, 332, 678–679.
   18. www.well-connected.com/rreports/doc06full.html
   19. www.well-connected.con’i/rreports/doc06full.html
   20. Keyomarsi, K., Tucker, S.L., Buchholz, T.A., Callister, M., Ding, Y., Hortobagyi, G.N., Bedrosian, I. Knickerbocker, C., Toyofuku, W, Lowe, M., Herliczek, T.W, and Bacus, S.S., 2002. Cyclin E and Survival in Patients with Breast Cancer. N Engl J Med, 347, 1566–1575.
   21. Yancik, R. and Ries, L.A., 1994. Cancer in older persons. Magnitude of the problem – how do we apply what we know? Cancer, 74 (7 Suppl), 1995–2003.
   22. Silliman, R.A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, W B. and Lyman, G.H., Comprehensive geriatric oncology. Amsterdam: Harwood.
   23. Welch, H.G., Albertson, EC., Nease, R.E, Bubolz, T.A. and Wasson, J.H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577–584.
   24. Holmes, EE, 1994. Clinical course of cancer in the elderly. Cancer Control, 1, 108–114.
   25. Nixon, A.J., Neuberg, D., Hayes, D.E, Gelman, R., Connolly, J.L., Schnitt, S. and others, 1994. Relationship of patient age to pathological features of the tumor and prognosis for patients with stage I or II breast cancer./ Clin Oncol, 12, 888–894.
   26. Balducci, Lodovico and Phillips, D. Melissa. 1998. Breast cancer in older women. American Family Physician. October 1, 1998. www.aafp.org/afp/981001 ap/balducci.html
   27. www.well-connected.com/rreports/doc06full.html
   28. Medical Report: Prostate Cancer. ICON, 2002, 1 (5), 8-10.
   29. Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
   30. http://www.nccn.org/paticnt_gls/_english/_prostate/
   31. http://www.nccn.org/patient_gls/_english/_prostate/
   32. Hart, D. and Wall, 2004. UK population dose from medical examinations. European Journal of Radiology, 50 (3), 285–291, Brenner, D.I. and others, 2001. CT scanning of children has been calculated 10 increase their lifetime risk of cancer. American Journal of Roentology, 176, 289–296.
   33. http://www.nccn.org/patient_gls/_english/_prostate/
   34. http://www.cancer.org
   35. Spurgeon, David, 2003. Advanced scanning techniques help doctors stage prostate cancer. BMJ, 326, 1418.
   36. New England Journal of Medicine, 2003, 348, 2491–2499.
   37. http://www.nccn.org/patient_gls/_english/_prostate/
   38. Fisher, B. and others, 2002. Twenty year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine, 347 (16), 1233–1241.
   39. Fisher, B., Bryant, J., Dignam, J.J., Wickerham, D.L., Mamou-nas, E.F., Fisher, E.R., Margolese, KG., Nesbitt, L., Paik, S., Pisansky, T.M., Wolmark, N., 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less./ Clin Oncol, 20 (20), 4141–4149; www.ncbi.nlm.nih.gov; 80
   40. Fisher, B., Anderson, S., Bryant, J., Margolese, R.G., Deutsch, M., Fisher, E.R., Jeong, J.H. and Wolmark, N., 2002. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347 (16), 1233–1241; www.ncbi.nlm.nih.gov; 80
   41. Gottlieb, Scott. Lumpectomy is as effective as mastectomy for breast cancer. BMJ, 325, 921.
   42. www.nlm.nih.gov/medlineplus/ency/article/002919.htm
   43. www.nlm.nih.gov/medlineplus/ency/article/002919. htm
   44. www.cancer.org/docroot/cri/content/cri_2_6x_breast_recon-struction_after_mastectomy_5.asp
   45. Bartelinkh and others, 2001. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England J Med, 345 (19), 1378–1387.
   46. http://cis.nci.nih.gov/fact/7_l6.htm
   47. Morrow, Monica and Gradishar, William, 2002. Recent Development: Breast Cancer. BMJ, 324, 410–414.
   48. Coombes, R.C. and others, 2006. American Society of Clinical Oncology, Annual Meeting, Atlanta Georgia, June 2006.
   49. Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ, 325, 1051–1052.
   50. www.gene.com/gene/products/information/oncology/ herceptin;
   www.herceptin.com/herceptin/ physician/pi.htm
   51. www.herceptin.com/herceptin/physician/pi.htm
   52. Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ, 332–443.
   53. Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118–1120.
   54. Daily Mail, Monday, 9 October, 2006.
   55. www.ahrq.gOv/news/press/pr2002/brchempr.htm
   56. http://cis.nci.nih.gov/fact/7_ 16.htm
   56. http://cis.nci.nih.gov/fact/ 7_16. htm
   57. Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ, 325, 7.
   58. http://cis.nci.nih.gov/fact/7_16. htm
   59. Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ, 324, 1539
   60. www.gene.com/gene/products/information/oncology/hercep-tin;
   www.herceptin.com/herceptin/physician/pi.htm
   61. http://cis.nci.nih.gov/fact/7_45. htm
   62. www.ahrq.gov/news/press/pr2002/brchempr.htm
   63. New Scientist, 20 January, 2007.
   64. Editorial, New Scientist, 31 March, 2007.
   65. Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ, 324, 1113.
   66. Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ, 325, 269–271.
   67. www.cancer.gov
   68. Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99-1136: www.cancer.gov/cancerinfo/chemorherapy-and-you
   69. Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ, 332, 162–181.
   70. Allison, R. and others, 2006.Photodiagnosis and photodynamic therapy, 3, 139–146.
   71. Fritsch, С. and Ruzika, Т., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.
   72. Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.
   73. Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.
   74. Ernst, E., 2003. Herbal medicines put into context. BMJ, 327, 881–882.
   75. Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
   76. Dyer, Owen, 2003. Aspirin could be used to prevent cancer. BMJ, 326, 565.
   77. Flower, Rod, 2003. What are all the things that aspirin does? BMJ, 327, 572–573.
   78. UK limits use of aspirin by under 16s. BMJ, 2002, 324, 1294.
   79. Astralagus. ICON, 2002, 1 (3), 23.
   80. Bartram, Т., 1998. Bartram’s encyclopedia of herbal medicine. Robinson publishing.
   81. Campbell, T.C. and Campbell, T.M., 2006. The China Study. Benbella Books.
   82. Greenwald, Peter, 2002. Cancer chemoprevention. BMJ, 324, 714–718.
Чтение онлайн



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 [69] 70 71 72 73 74 75 76 77

Навигация по сайту
Реклама


Читательские рекомендации

Информация